Accéder au contenu
Merck

Prevention of contrast-induced nephropathy: the rational use of sodium bicarbonate.

Nephrology nursing journal : journal of the American Nephrology Nurses' Association (2007-09-26)
Reymond Barreto
RÉSUMÉ

The incidence of contrast-induced nephropathy (CIN) is increasing due to the growing number of patients undergoing radiocontrast studies. CIN is associated with a mortality rate as high as 34%. The purpose of this article is to review the strategies for preventing CIN and explore the role of sodium bicarbonate in this setting. A review of current literature suggests that prophylactic N-acetylcysteine and hydration with sodium bicarbonate may be the best pharmacological approach to preventing CIN. This article provides the dosing, administration, and monitoring guidelines for sodium bicarbonate, as well as implications for the nephrology nurse.

MATÉRIAUX
Numéro du produit
Marque
Description du produit

Sigma-Aldrich
Bicarbonate de sodium, ACS reagent, ≥99.7%
Sigma-Aldrich
Bicarbonate de sodium, powder, BioReagent, Molecular Biology, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Bicarbonate de sodium, ReagentPlus®, ≥99.5%, powder
Sigma-Aldrich
Bicarbonate de sodium solution, solution (7.5%), sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Bicarbonate de sodium, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E500, 99.0-100.5%, powder
Sigma-Aldrich
Bicarbonate de sodium, BioXtra, 99.5-100.5%
USP
Bicarbonate de sodium, United States Pharmacopeia (USP) Reference Standard
Supelco
Bicarbonate de sodium solution, 0.1 M NaHCO3 in water, eluent concentrate for IC
Sigma-Aldrich
Bicarbonate de sodium, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Bicarbonate de sodium, −40-+140 mesh, ≥95%
Sigma-Aldrich
Bicarbonate de sodium, tested according to Ph. Eur.
Sigma-Aldrich
Sodium bicarbonate-12C, 99.9 atom % 12C